CPM
PFE icon

Chesapeake Partners Management’s Pfizer PFE Stock Holding History

Chesapeake Partners Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-221,833
Closed -$5.89M – 94
2013
Q2 		$5.89M Buy
+221,833
New +$6.13M 0.38% 66

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Chesapeake Partners Management's PFE Position: Q3 2013 in Review

Chesapeake Partners Management sold out of Pfizer (PFE) in Q3 2013, closing a stake of 221,833 shares — an estimated $5.89M sold.

Chesapeake Partners Management first reported a position in PFE in Q2 2013 and held it in 1 quarter. The position peaked at $5.89M in Q2 2013. 1,606 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Chesapeake Partners Management reported no remaining Pfizer position as of Q3 2013 after selling out during the quarter.
  • Chesapeake Partners Management sold 221,833 Pfizer shares in Q3 2013, an estimated $5.89M.
  • Chesapeake Partners Management first reported a position in Pfizer in Q2 2013 and held it in 1 quarter.
  • Chesapeake Partners Management's Pfizer position peaked at $5.89M in Q2 2013.
  • 1,606 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Chesapeake Partners Management's 13F filing for Q3 2013, filed 14 Nov 2013.